ADR Biomedical Holdings Inc. (TYO:3750)

ADR Biomedical Holdings Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	7,464	7,268	7,160	8,643	10,116	10,349
Market Cap Growth	-11.91%	1.49%	-17.15%	-14.56%	-2.25%	-17.56%
Enterprise Value	7,647	7,422	9,377	15,692	17,439	18,781
Last Close Price	836.00	814.00	802.00	968.00	1133.00	1159.00

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	-	-	-	62.63	-	-
PS Ratio	73.90	145.35	58.69	5.54	4.72	7.75
PB Ratio	-105.12	330.34	11.37	3.09	3.81	2.79
P/TBV Ratio	-	330.34	11.40	3.12	5.15	3.48

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	75.71	148.43	76.86	10.06	8.13	14.07

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	-3.52	-	4.20	0.88	3.20	2.49
Net Debt / Equity Ratio	-2.58	-5.68	3.80	0.51	2.78	2.27
Net Debt / EBITDA Ratio	-	0.15	-3.16	-2.76	-15.88	-59.27
Net Debt / FCF Ratio	-	0.16	-2.40	-1.23	-37.48	-22.93
Asset Turnover	0.18	0.03	0.03	0.16	0.14	0.09
Inventory Turnover	0.71	0.75	1.76	2.45	0.99	0.14
Quick Ratio	0.41	0.80	0.52	2.05	1.05	0.97
Current Ratio	1.10	1.55	1.05	2.66	1.18	3.04
Return on Equity (ROE)	-267.63%	-121.47%	-125.00%	5.06%	-33.24%	-2.12%
Return on Assets (ROA)	-98.70%	-29.03%	-10.79%	-4.85%	-3.30%	-1.87%
Return on Invested Capital (ROIC)	-	-62.14%	-22.26%	-10.84%	-7.17%	-3.99%
Return on Capital Employed (ROCE)	-1806.20%	-638.70%	-26.50%	-14.60%	-6.20%	-3.10%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	-7.48%	-5.45%	-29.89%	1.60%	-10.47%	-0.74%
FCF Yield	-10.50%	-10.79%	-13.90%	-13.53%	-1.95%	-3.55%
Buyback Yield / Dilution	0.00%	0.00%	0.34%	-0.34%	-1.12%	-7.89%
Total Shareholder Return	0.00%	0.00%	0.34%	-0.34%	-1.12%	-7.89%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 15, 2026

Data Sources Report a data error